Login to Your Account



Oncologic Drugs Advisory Committee Meeting

Clofarabine: Endorsed For Use In ALL, But Not AML

By Aaron Lorenzo


Thursday, December 2, 2004
SILVER SPRING, Md. - The FDA's Oncologic Drugs Advisory Committee split its vote regarding clofarabine, ILEX Oncology Inc.'s cancer product. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription